Viewing Study NCT02264067


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-01-05 @ 12:31 AM
Study NCT ID: NCT02264067
Status: COMPLETED
Last Update Posted: 2014-10-15
First Post: 2014-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module